The present invention relates to new substituted five-membered compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula: ##STR00001##

 
Web www.patentalert.com

< Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer

> Beta-like glycoprotein hormone polypeptide and heterodimer

~ 00487